Navigation Links
Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica
Date:6/12/2008

ROSEAU, Commonwealth of Dominica, June 12 /PRNewswire/ -- Neuftec Limited, the proprietor of the original nano-particulate cerium Oxide fuel catalyst technology, today commenced patent infringement litigation in the UK against Oxonica Energy Limited, a wholly owned subsidiary of Oxonica PLC . The proceedings, issued in the High Court of Justice, allege infringement of Neuftec's European patent.

The proceedings seek an injunction against Oxonica as well as damages in relation to product already sold and delivery up or destruction of all articles that would infringe Neuftec's European patent.

Oxonica and its legal advisors have previously made statements on at least two occasions that they have no intention of dealing with products that infringe any of Neuftec's issued patents. However, despite these statements it is with regret that this is the second time, to the best of Neuftec's knowledge, that Oxonica has infringed its granted patents.

The first infringement came in May 2007 when it came to Neuftec's knowledge that Oxonica infringed the claims of Neuftec's Australian patent by collecting a shipment of Envirox without the knowledge, consent or authorization of Neuftec. This stock is estimated by Neuftec to have a resale value of approximately US$1.8 million and cannot be used or sold without Neuftec's permission. It has been stored in a warehouse in Australia since March 2007.

The latest alleged infringement occurred when Oxonica shipped Envirox formulations to Italy for use in Italian Government laboratory emission testing.

Neuftec is continuing it's investigations with customers, distributors & agents of Oxonica to determine the extent of the alleged infringement

Neuftec is represented in these proceedings by Watson, Farley & Williams LLP & Mr. Mark Platts-Mills QC of 8 New Square, London.

About Neuftec

Neuftec is a research & development company that owns patents in the fuel catalyst technology sector used in the production of the first version of EnviroxTM (2001-2007) that was manufactured by Advanced Nanotechnology ("ANO") of Australia under a manufacturing licence granted by Oxonica with authorization from Neuftec.

On 29 February 2008, IP Australia issued a re-examination report in respect of Neuftec's Australian patent. The patent had been issued in 2006 with 10 claims. In the re-examination report, IP Australia confirmed the patentability of the 10 claims as originally granted in 2006 in re-examination proceedings initiated by Oxonica.


'/>"/>
SOURCE Neuftec Limited
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharmos Issues Letter to Shareholders
2. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
3. HHS Issues First Department-Wide Report on Personalized Health Care
4. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
5. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
6. CCPM Issues Statement on FDAs GIVE Initiative
7. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
8. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
9. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
10. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
11. Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, a Chicago-based ... recent FDA Class II 510(k) clearance for their flagship medical device, SimplECG. , ... cardiac monitoring devices that rely on cloth-based nanosensors. While other companies have attempted ...
(Date:12/2/2016)... 1, 2016   SurePure, Inc. (OTCQB: SURP) ... the Company has concluded an agreement with Tamarack Biotics ... 90-day period to acquire units of the Company,s patented ... 3.7 million.  Concurrently with the option, ... which Tamarack will seek regulatory approvals in ...
(Date:11/30/2016)... ... 2016 , ... BEI Kimco, a brand of Sensata Technologies, ... that ensures high alignment accuracy by preventing unwanted shaft rotation. The new VCA ... precision is required, such as in medical equipment, laboratory instrumentation, clean rooms, low-outgassing ...
Breaking Biology Technology:
(Date:11/28/2016)... "The biometric system market ... The biometric system market is in the growth stage ... future. The biometric system market is expected to be ... CAGR of 16.79% between 2016 and 2022. Government initiative ... in smartphones, rising use of biometric technology in financial ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, a ... for public safety, investigation, corrections and monitoring, announced today ... competitor, ICSolutions, to have an independent technology judge determine ... most modern high tech/sophisticated telephone calling platform, and the ... that they do most of what we do – ...
(Date:11/15/2016)... DUBLIN , Nov 15, 2016 Research ... - Global Forecast to 2021" report to their offering. ... ... reach USD 16.18 Billion by 2021 from USD 6.21 Billion in ... Growth of the bioinformatics market is driven by ...
Breaking Biology News(10 mins):